CHONGQING PHARSCIN PHARMACEUTICAL CO.,LTD. – Trademark Portfolio
Entity Type: 03
CHONGQING PHARSCIN PHARMACEUTICAL CO.,LTD. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PHARSCIN. The owner is based in CHONGQING.
INDUSTRIAL PARK, RONGCHANG DISTRICT
CHONGQING 402460 , CN
Showing of trademarks Trademarks
Trademark Classifications
CHONGQING PHARSCIN PHARMACEUTICAL CO.,LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does CHONGQING PHARSCIN PHARMACEUTICAL CO.,LTD. have?
CHONGQING PHARSCIN PHARMACEUTICAL CO.,LTD. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does CHONGQING PHARSCIN PHARMACEUTICAL CO.,LTD. file in?
CHONGQING PHARSCIN PHARMACEUTICAL CO.,LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CHONGQING PHARSCIN PHARMACEUTICAL CO.,LTD.'s most well-known trademarks?
CHONGQING PHARSCIN PHARMACEUTICAL CO.,LTD.'s registered trademark portfolio includes well-known marks such as PHARSCIN. These are among 3 currently registered trademarks in the portfolio.
What is CHONGQING PHARSCIN PHARMACEUTICAL CO.,LTD.'s trademark registration success rate?
CHONGQING PHARSCIN PHARMACEUTICAL CO.,LTD. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.